Kämpfender Krebs

Willkommen zum Wochenende!  Ergreifen Sie eine heiße Schale Kaffee, und lesen Sie die neuesten Forschung Entwicklungen im Krebs dieser Monat in Ihren Pyjamas:

Wirklich bilden Sie das einen dämpfenden Becher vom Kräutermaterial:  Gloria rüber an Krebs-Kommentar (und selbstverständlich, Kämpfende Arthritis)  hat mehr Informationen über, wie man in einer grünen Teeprostatakrebs-Verhinderungstudie einschreibt, die im Augenblick in der Moffit Krebs-Mitte weitergeht.

Überprüfen Sie heraus ihren Pfosten an „Moffit sucht grüne Tee-Studie Teilnehmer.”

Mehr →

Teilen Sie dieses

Ist hier ein schneller flüchtiger Blick an einigen interessanten Krebsforschungstudien, die vor kurzem herausgekommen sind, hier redigiert für Ihr Wochenende Lesevergnügen - genießen Sie!

Verpflanzende Mörderzellen in Krebspatienten: Anscheinend gibt es einige Leute gerade sind nicht vornübergeneigt zum Erhalten des Krebses wegen höheres als normalen gesunden Vorrats an immunes System Soldaten, die granulocytes angerufen werden. Spur-Wald Universität-gründete Dr. Zheng Cuit und seine Kollegen schauen, um zu sehen, wenn sie einige jener von Geburt Mörderzellen in Krebspatienten verpflanzen können - um, solange es nicht Grippejahreszeit ist.

Durchschnittliche Krebstötung Fähigkeit schien, niedriger in den Leuten mit Krebs niedriger in den Erwachsenen über dem Alter von 50 und gleichmäßig zu sein. Es fiel auch, als Leute betont wurden, und zu bestimmten Zeiten des Jahres.

Mehr →

Teilen Sie dieses

I know that I’m not saying anything new with this post, but after reading an recent article answering the question “Did the Marlboro Man Die of Lung Cancer?”, I had to wonder if there was anyone else out there aware of the sharp, poetic irony associated with the death of not one, but two men who played the role of the Marlboro Man in ads for Marlboro cigarettes. Didn’t they get the memo that smoking is bad?

To be fair, at least thirteen men have played the Marlboro Man throughout the years and only two have died of lung cancer: Wayne McClaren in 1992, and David McClean in 1995. And also to be fair, at the time these gentlemen began their stints on the Marlboro Man ad campaign, cigarettes were not yet associated with a high risk of cancer development and more importantly, smoking was supposed to be cool.

Fortunately, times have changed, and we are now fully aware of the deadly risks associated with tobacco use and cancer. A quick search on the American Cancer Society web site states that smoking is responsible for 1 in 5 deaths in the US alone, and that tobacco use accounts for about 30% of all cancer deaths and 87% of all lung cancer deaths.

Anyway, back to the whole Marlboro Man ad campaign: what a racket that was! That was quite possibly the most genius ad campaign ever conceived. What woman has not dreamed of a rough and rugged cowboy, noticeable stubble enhancing an unbelievably handsome-as-sin face, wearing chaps and riding up on a stallion complete with a saddle made for two? This was a brilliant advertising strategy. Who cares if this guy is lighting up? He’s smoking hot! (Okay, that was bad — I admit it.) More →

Share This

By Ajishnu Sharma

General Information on Lung Cancer

Lung cancer, or carcinoma of the lung, is one of the most common forms of cancer today. It is one of the most frequent causes of cancer-related mortality in the United States today. In the United States, another form of cancer that is becoming increasingly common is breast cancer, which is the development of malignant tissue in the breast. Breast cancer is seen mostly in women, though this does not mean that men are immune to it. A small percentage of men too contract breast cancer. The numbers are small, 1 man with breast cancer against a 100 women with it, but its there. However, there is one major difference between breast cancer and lung cancer. One can see the symptoms of breast cancer at an early stage, while in the case of lung cancer, the symptoms are not detected early, primarily because they match the symptoms of other lesser ailments. In this article, we will discuss lung cancer.

A person is said to suffer from lung cancer when a growth of malignant cancer cells is detected in the lungs. Depending on the stage at which lung cancer is detected, it can be classified as being in the:

More →

Share This

By David Silva

Unlike other forms of lung cancer, metastatic lung cancer is the result of a cancer from another part of the body spreading to the lungs. When a malignancy develops in the body (most often in the breasts, colon, prostate, or bladder, though almost all cancers have the ability to spread) it can sometimes spread through the blood stream. When these malignancies settle into the pulmonary tissues, such as the alveoli (the final vein-like branches of the respiratory system) and the supporting tissues of the respiratory structures, the cancer has metastasized to the lungs.

Unfortunately, treating metastatic lung cancer presents significant challenges. Since the cancer has spread from another part of the body, treatment not only involves addressing the cancer in the lungs, but also the original cancer and any other areas of the body that may have also become affected. In some cases, if the primary tumor is successfully removed and if the spread of the tumor cells to the pulmonary regions is relatively localized, then the management of the cancer by surgical techniques may do the job. However, if the metastatic lung cancer is extensive, because so many areas of the body may be under the influence of the cancer, certain treatments (such as surgery, and in many cases, radiation therapy as well) may prove ineffective. Which leaves most patients with chemotherapy as the primary treatment of choice.

More →

Share This

San Francisco Business Times - 2:51 PM PST Thursday

Cytokinetics Inc. said Thursday that a clinical trial of ispinesib, an experimental lung cancer treatment, failed.

The South San Francisco drug company (NASDAQ: CYTK) said the Phase II trial, run by GlaxoSmithKline, failed to meet the criteria to advance to the next stage of clinical testing.

More →

Share This

By Dr. Shalini Mulaparthi
For the Times Herald-Record

The recent death of Dana Reeve from lung cancer at age 44 put a spotlight on a devastating disease whose causes and prevention are frequently misunderstood.

In fact, it’s the very attention being given to the disease that is creating much of the confusion: Whenever circumstances increase the amount of public dialogue surrounding a serious disease, it can become difficult to distinguish between the useful and misguided - or outright false - information.

More →

Share This

When Dana Reeve, widow of actor Christopher Reeve, died of lung cancer, the stories of her death pointed out that she didn’t smoke. She was young, only 44; she had nursed her paralyzed husband for eight years; she left a 13-year-old son an orphan. And how could she have gotten lung cancer? She had never smoked.Lung cancer is often preventable, and it is usually fatal.

Unfortunately I will also become a victim of this disease. Not for myself, but a victim because I am a friend of a lung cancer person. One of my very dearest friends will undergo a lung operation this coming Tuesday.

According to the American Lung Association, 87 percent of lung cancer cases are caused by smoking. Another 12 percent are linked to radon exposure.

Only 15 percent of people diagnosed with the disease will still be alive five years after the diagnosis; 60 percent die within the first year. What is Chemoprevention? For individuals who demonstrate the greatest risk, researchers are currently conducting several new trials to test the use of natural and synthetic substances to prevent development of the disease. This new research has been coined, chemoprevention. More →

Share This